NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
NSF's Tech Accelerators Aim to Bridge the 'Valley of Death'
The agency aims to connect researchers with investors to bring emerging technologies in specific areas to market faster.
2m read -
USPIS Uses AI to Advance Criminal Investigations
The U.S. Postal Inspection Service is using AI to uncover crime patterns, support investigations and improve workforce efficiency.
5m watch -
Advice for the Next Generation of Cybersecurity Professionals
Author Agathe Merle discussed breaking barriers in cybersecurity, fostering inclusion and using creativity to strengthen cyber defense.
29m watch -
How Army Contracting Command is Using AI in Acquisition
Army Contracting Command’s Jordan Duke discusses AI adoption, cybersecurity risks and securing acquisition operations across the Army enterprise.
9m listen
